Profil von »VWZMinerva«

VWZMinerva

EVE-Member
- Registrieren Sie sich jetzt!
Sie müssen sich registrieren, um eine Verbindung mit diesem Benutzer herzustellen.

[img]http://media5.picsearch.com/is?cVu7vm1waO12hRSkUezgOMfurDNAz8NlxD2rKoMuypE Hazard Ratio (HR) of 0.52,
pSimilar Efficacy Benefit for Duvelisib Monotherapy Over Ofatumumab for Patients with 17p Deletion (Median PFS of 12.7 versus 9.0
Months, Respectively; HR of 0.41, p=0.0011)Oral Duvelisib Continues to Demonstrate a Consistent and Manageable Safety
Profile."Now, while there are multiple treatment options in the market for CLL, duvelisib is oral and can theoretically be used at home. Also, while ofatumumab is one of the earlier treatment options in CLL, the results from duvelisib were significantly better iphone 8 plus case.[/img]